BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 24680477)

  • 1. Antimalarial drugs inhibit IFNα-enhanced TNFα and STAT4 expression in monocytes: implication for systemic lupus erythematosus.
    López P; Rodríguez-Carrio J; Suárez A
    Cytokine; 2014 May; 67(1):13-20. PubMed ID: 24680477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokine polymorphisms influence treatment outcomes in SLE patients treated with antimalarial drugs.
    López P; Gómez J; Mozo L; Gutiérrez C; Suárez A
    Arthritis Res Ther; 2006; 8(2):R42. PubMed ID: 16507146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of functional interleukin 10/tumor necrosis factor-alpha polymorphisms on interferon-alpha, IL-10, and regulatory T cell population in patients with systemic lupus erythematosus receiving antimalarial treatment.
    López P; Gómez J; Prado C; Gutiérrez C; Suárez A
    J Rheumatol; 2008 Aug; 35(8):1559-66. PubMed ID: 18597405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutralization of interferon-alpha/beta-inducible genes and downstream effect in a phase I trial of an anti-interferon-alpha monoclonal antibody in systemic lupus erythematosus.
    Yao Y; Richman L; Higgs BW; Morehouse CA; de los Reyes M; Brohawn P; Zhang J; White B; Coyle AJ; Kiener PA; Jallal B
    Arthritis Rheum; 2009 Jun; 60(6):1785-96. PubMed ID: 19479852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TLR9 independent interferon α production by neutrophils on NETosis in response to circulating chromatin, a key lupus autoantigen.
    Lindau D; Mussard J; Rabsteyn A; Ribon M; Kötter I; Igney A; Adema GJ; Boissier MC; Rammensee HG; Decker P
    Ann Rheum Dis; 2014 Dec; 73(12):2199-207. PubMed ID: 24013727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of the interferon-alpha production induced by RNA-containing immune complexes in plasmacytoid dendritic cells.
    Eloranta ML; Lövgren T; Finke D; Mathsson L; Rönnelid J; Kastner B; Alm GV; Rönnblom L
    Arthritis Rheum; 2009 Aug; 60(8):2418-27. PubMed ID: 19644885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Artesunate inhibits type I interferon-induced production of macrophage migration inhibitory factor in patients with systemic lupus erythematosus.
    Feng X; Chen W; Xiao L; Gu F; Huang J; Tsao BP; Sun L
    Lupus; 2017 Jan; 26(1):62-72. PubMed ID: 27230555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of 5C11-positive activated interferon-producing cells in patients with systemic lupus erythematosus.
    Ohshima M; Kanda H; Kubo K; Yonezumi-Hayashi A; Tateishi S; Yamamoto K
    Lupus; 2013 Jan; 22(1):44-51. PubMed ID: 23087259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monocytes and T lymphocytes contribute to a predominance of interleukin 6 and interleukin 10 in systemic lupus erythematosus.
    Mellor-Pita S; Citores MJ; Castejon R; Yebra-Bango M; Tutor-Ureta P; Rosado S; Andreu JL; Vargas JA
    Cytometry B Clin Cytom; 2009 Jul; 76(4):261-70. PubMed ID: 19199277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum-dependent enhancement of coxsackievirus B4-induced production of IFNα, IL-6 and TNFα by peripheral blood mononuclear cells.
    Alidjinou EK; Sané F; Engelmann I; Hober D
    J Mol Biol; 2013 Dec; 425(24):5020-31. PubMed ID: 24120940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of interferon-alpha by immune complexes or liposomes containing systemic lupus erythematosus autoantigen- and Sjögren's syndrome autoantigen-associated RNA.
    Lövgren T; Eloranta ML; Kastner B; Wahren-Herlenius M; Alm GV; Rönnblom L
    Arthritis Rheum; 2006 Jun; 54(6):1917-27. PubMed ID: 16729300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-phospholipid antibodies contribute to arteriosclerosis in patients with systemic lupus erythematosus through induction of tissue factor expression and cytokine production from peripheral blood mononuclear cells.
    Motoki Y; Nojima J; Yanagihara M; Tsuneoka H; Matsui T; Yamamoto M; Ichihara K
    Thromb Res; 2012 Oct; 130(4):667-73. PubMed ID: 22196362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of interleukin-12 and its signaling molecules in peripheral blood mononuclear cells in systemic lupus erythematosus patients.
    Li Z; Li Y; Huang L; Xu H; Yu X; Ye R
    Chin Med J (Engl); 2002 Jun; 115(6):846-50. PubMed ID: 12123550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C1q inhibits immune complex-induced interferon-alpha production in plasmacytoid dendritic cells: a novel link between C1q deficiency and systemic lupus erythematosus pathogenesis.
    Lood C; Gullstrand B; Truedsson L; Olin AI; Alm GV; Rönnblom L; Sturfelt G; Eloranta ML; Bengtsson AA
    Arthritis Rheum; 2009 Oct; 60(10):3081-90. PubMed ID: 19790049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of antimalarial treatment on IL-1beta, IL-6 and TNF-alpha mRNA expression on UVB-irradiated skin in systemic lupus erythematosus.
    Wozniacka A; Lesiak A; Boncela J; Smolarczyk K; McCauliffe DP; Sysa-Jedrzejowska A
    Br J Dermatol; 2008 Nov; 159(5):1124-30. PubMed ID: 18764842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PTPN22 Variant R620W Is Associated With Reduced Toll-like Receptor 7-Induced Type I Interferon in Systemic Lupus Erythematosus.
    Wang Y; Ewart D; Crabtree JN; Yamamoto A; Baechler EC; Fazeli P; Peterson EJ
    Arthritis Rheumatol; 2015 Sep; 67(9):2403-14. PubMed ID: 26018863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monocyte response to LPS after exposure to corticosteroids and chloroquine with implications for systemic lupus erythematosus.
    Cepika AM; Bendelja K; Vergles JM; Malenica B; Kapitanovic S; Gagro A
    Scand J Immunol; 2010 Nov; 72(5):434-43. PubMed ID: 21039738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coordinate overexpression of interferon-alpha-induced genes in systemic lupus erythematosus.
    Kirou KA; Lee C; George S; Louca K; Papagiannis IG; Peterson MG; Ly N; Woodward RN; Fry KE; Lau AY; Prentice JG; Wohlgemuth JG; Crow MK
    Arthritis Rheum; 2004 Dec; 50(12):3958-67. PubMed ID: 15593221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease.
    Kirou KA; Lee C; George S; Louca K; Peterson MG; Crow MK
    Arthritis Rheum; 2005 May; 52(5):1491-503. PubMed ID: 15880830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Large-scale analysis of tumor necrosis factor α levels in systemic lupus erythematosus.
    Weckerle CE; Mangale D; Franek BS; Kelly JA; Kumabe M; James JA; Moser KL; Harley JB; Niewold TB
    Arthritis Rheum; 2012 Sep; 64(9):2947-52. PubMed ID: 22488302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.